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Abstract  
BACKGROUND: Type 1 Diabetes Mellitus (T1DM) is one of the most common chronic endocrine 
disorders of childhood. Data on growth parameters of diabetic children is scarce. 
AIM: To assess growth and body composition in a group of diabetic children.  
SUBJECTS AND METHODS: 427 T1DM children (age 2-10 years) were recruited from Diabetic 
Paediatric Unit, outpatients' clinic of Abou El-Rish Hospital. Anthropometric and body composition 
parameters were taken and HbA1c was measured for all subjects. 
RESULTS:  Highly significant difference was detected between controlled and uncontrolled groups 
as regard to weight/age z-score, height/age z-score, BMI z-score, triceps skin fold thickness, 
subscapular skin fold thickness, midupper arm circumference, fat mass, fat %, lean mass, and body 
water (p < 0.001). All values are higher in the controlled group than in the uncontrolled group. 
Uncontrolled subjects were significantly more at risk of being underweight and short, with odds ratio 
of 15.131 and 16.877 and 95% confidence interval 1.972-116.130 and 3.973-71.694 respectively. 
However, controlled subjects were significantly more at risk of being obese than the uncontrolled 
with an odds ratio 0.116 and 95% confidence interval 0.045-0.302. 
CONCLUSION: Growth was compromised in uncontrolled T1DM children. This is of utmost 
importance since most of the clinical features are reversible with better glycemic control and 
appropriate insulin management. 
 
 
 
Introduction 
 
Type 1 diabetes mellitus (T1DM) is the most 
common chronic metabolic disorder in youth and its 
incidence is increasing worldwide [1]. It is a complex 
disease, resulting from multiple genetic and 
environmental etiological factors. The long preclinical 
prodrome raises the possibility of intervention to delay 
or prevent clinical onset of disease [2]. It is 
characterized by chronic hyperglycemia and body 
composition is important in the disease control [3]. 
T1DM accounts for 5-10% of the total number 
of cases of diabetes mellitus worldwide. There has 
been a steady increase in type 1 diabetes incidence in 
children <15 yr [2, 4].  It appears to have been 
particularly pronounced among children <5 years of 
age [5]. Diabetes prevalence in some Eastern 
Mediterranean countries is among the highest in the 
world. The highest rates are reported in Egypt, 
Kuwait, Lebanon, Oman and Qatar where the 
incidence of type 1 diabetes is reported to be 8-10 per 
100.000 population per year in children aged <15 
years [6]. T1DM incidence and prevalence showed a 
progressive increase over a period of 18 years among 
children aged from 0 to 18 years living in the Nile 
Delta region (Egypt). In 2011, incidence and 
prevalence in Egypt was 3.1/10
5
/year and 26.8/10
5
 
Egyptian children from 0-18 years old respectively [7]. 
T1DM affects children of all ages, both sexes, 
and all ethnic groups [2].  In the pediatric age group, 
the growth is a good indicator of health, and 
consequently achieve normal growth speed is one of 
the goals of doctors who treat diabetic children [8].  
Low portal insulin concentrations, documented in 
children with T1D, result in low circulating levels of 
IGF-I and IGFBP-3, and high circulating levels of 
IGFBP-1 with subsequent increased risk of developing 
growth failure [9]. 
Several studies have suggested growth 
retardation in children with type 1 diabetes with 
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suboptimal diabetes control whereas other studies 
have demonstrated normal growth in children with 
good metabolic control [10].   Insulin is used to control 
blood glucose but may have an adverse effect on the 
amount and distribution of fat mass [11] and hence 
body composition. Available literature on body 
composition in children and adolescents with type 1 
diabetes is scarce. Intensification of insulin therapy 
may result in leptin resistance and excessive gains in 
fat mass, particularly in girls [12]. 
The aims of this study are: 1) to assess 
growth of the diabetic children and their body 
composition, and 2) to realize the difference in 
anthropometric and body composition variables 
between diabetic uncontrolled and diabetic controlled 
children. 
 
 
Subjects and Methods 
 
The present study was a cross-sectional 
study comprising 427 diabetic children. They were 
recruited from Diabetic Endocrine Metabolic 
Paediatric Unit, (DEMPU) outpatients' clinic of Abou 
El-Rish Hospital, Cairo University in the period from 
May 2013 to May 2014. They were divided into 2 
groups:  212 diabetic uncontrolled and 215 diabetic 
controlled (214 boys and 213 girls) according to the 
average of their glycated Haemoglobin (HbA1c) 
during the last year (cutoff value is < 8 %). The 
parents and students’ approval were taken as a 
written consent. The study was approved by Ethical 
and Research Committee of the Council of Children 
Department, Cairo University, as well as by Ethical 
Committee of the National Research Centre. The 
sample has been chosen from pre-adolescents to 
avoid the physiological and psychological changes 
accompanying growth and pubertal development, all 
of them were from the same low to middle 
socioeconomic class. 
Diabetic children included in the study should 
be already diagnosed as T1DM and receiving insulin 
treatment for at least 1 year. Children with any genetic 
or chronic diseases that can affect their growth e.g. 
cardiac or renal disease were excluded. Any child with 
any signs of evidence of puberty was also excluded. 
Simple questionnaire was done for each 
patient with a complete physical examination, 
including anthropometric measures (weight, height, 
midupper arm circumference, triceps and subscapular 
skinfold thickness). All measurements were taken 
according to the recommendations of International 
Biological programs [13]. Then, BMI was calculated as 
weight (kg)/height
2
 (m
2
). Weight, height 
measurements were converted to z-scores (weight-
for-age, and height-for-age), based on WHO child 
growth standards. A cut off of ≤ –2 z scores for these 
indices was used for classifying children as 
underweight and stunting, while cut off of ≥ 2 z-scores 
of BMI was used for classifying obesity.  
 
Body Composition Analysis 
Body composition analysis in this study was 
based on the bioelectrical impedance technique. The 
body bioelectrical impedance was measured using 
body fat analyzer MODEL: BT-905. It is a device used 
for the estimation of body composition. It gives 
accurate information about: Fat percent (%), lean (%), 
fat mass, basal metabolic rate (BMR), target weight 
and target fat (%), for an individual.  
 
Statistical analysis 
Statistical analysis was carried out using the 
statistical package for social sciences, version 16 for 
windows (SPSS Inc., USA). Continuous data were 
expressed as mean± SD and were compared using 
Student’s t-test. Categorical data were expressed as 
frequencies and percentages, and were analyzed with 
the two-tailed chi-square test. Pearson’s correlation 
analysis was carried out to evaluate the association 
between continuous exposure and continuous 
covariates. The chi-square (X
2
) test, odds ratio (OR) 
and 95% confidence interval (CI) were used to 
evaluate the association between diabetic control and 
growth deficit and obesity. Logistic regression was 
done to confirm the previous association after 
adjustment for age and sex. P value less than 0.05 
was considered as statistically significant. 
 
 
Results 
 
In the present study, the mean age of the 
subjects studied was 6.72 ± 2.08 with a mean age at 
the onset of T1DM was 4.18 ± 2.16 and mean 
duration of the disease 2.46 ± 1.53. Two hundred 
fourteen were male (50.1 %) and two hundred thirteen 
were female (49.9 %). No significant difference 
between male and female were detected as regard to 
anthropometric parameters and glycemic control (p > 
0.05). So, we considered both of them as one group 
for comparison.  
On comparing the different anthropometric 
and body composition parameters between controlled 
and uncontrolled T1DM in all subjects and in female 
subjects, highly significant values were detected in 
controlled group than in uncontrolled except for the 
lean   %   where   it   was   significantly   higher  in  the  
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Table 1: Comparison between controlled and uncontrolled 
T1DM as regard to anthropometric and body composition 
parameter in all subjects. 
 
Controlled 
 (No 215) 
Mean ± SD 
Uncontrolled 
 (No 212) 
Mean ± SD 
t-test P 
Weight/age z-score 1.203 ± 1.36 -0.873 ± 0.85 18.903 0.000* 
Height/age z-score 0.763 ± 1.57 -0.921 ± 0.94 13.438 0.000* 
BMI z-score 1.211 ± 0.96 0.056 ± 0.95 12.445 0.000* 
TSFT (mm) 13.03 ± 3.51 11.03 ± 3.55 5.874 0.000* 
SSFT (mm) 9.81 ± 4.81 7.79 ± 3.16 5.107 0.000* 
MUAC (cm) 19.79 ± 2.30 17.71 ± 2.22 9.539 0.000* 
Fat mass 4.82 ± 3.61 3.22 ± 2.91 5.061 0.000* 
Fat % 17.67 ± 10.54 13.83 ± 9.31 3.990 0.000* 
lean mass 22.41 ± 5.49 19.10 ± 4.57 6.770 0.000* 
Lean % 82.46 ± 10.44 85.80 ± 9.09 -3.521 0.000* 
Water 15.91 ± 4.14 13.33 ± 3.40 7.029 0.000* 
P < 0.001 is highly significant; BMI = Body mass index; TSFT = Triceps skin fold thickness; 
SSFT = Subscapular skin fold thickness; MUAC = Midupper arm circumference. 
 
uncontrolled than in the controlled group (p < 0.05) 
Table 1&2. This can be explained by the higher mean 
weight of the controlled group as the lean % = lean 
mass/body weight X 100. Same results were obtained 
when the same anthropometric and body composition 
parameters were studied in male subjects with the 
exception of fat % and lean %, which showed no 
significant difference between controlled and 
uncontrolled group (p > 0.05) Table 2. 
Table 2: Comparison between controlled and uncontrolled 
T1DM as regard to anthropometric and body composition 
parameter in both sex. 
 Controlled Uncontrolled t-test P 
 Mean ± SD Mean ± SD   
Male (No 106) (No 108)   
Weight/age z-score 1.311 ± 1.57  -1.004 ± 0.85 13.429 0.000* 
Height/age z-score 0.901 ± 1.77 -0.923 ± 0.86 9.615 0.000* 
BMI z-score 1.225 ± 1.05 0.004 ± 0.92 9.050 0.000* 
TSFT (mm) 12.55 ± 3.48 10.64 ± 3.36 4.088 0.000* 
SSFT (mm) 8.89 ± 3.38 7.59 ± 3.09  2.938 0.004* 
MUAC (cm) 19.74 ± 2.47 17.26 ± 2.23 7.718 0.000* 
Fat mass 4.86 ± 3.44 3.78 ± 2.95 2.468 0.014* 
Fat % 17.89 ± 10.57 16.33 ± 9.69 1.130 0.260 
lean mass 23.25 ± 5.64 18.80 ± 4.63 6.309 0.000* 
Lean % 82.02 ± 10.50 83.32 ± 9.42 -0.957 0.340 
Water 16.51 ± 4.20 12.96 ± 3.44 6.763 0.000* 
Female (No 109) (No 104)   
Weight/age z-score 1.097 ± 1.11 -0.737 ± .83 13.618 0.000* 
Height/age z-score 0.628 ± 1.33 -0.919 ± 1.03 9.463 0.001* 
BMI z-score 1.197 ± 0.876 0.112 ± 0.99 8.502 0.000* 
TSFT (mm) 13.51 ± 3.49 11.44 ± 3.70 4.203 0.000* 
SSFT (mm) 10.70 ± 5.76 8.00 ± 3.24 81.47 0.000* 
MUAC (cm) 19.84 ± 2.13 18.176 ± 2.12 5.740 0.000* 
Fat mass 4.78 ± 3.77 2.63 ± 2.76 81.45 0.000* 
Fat % 17.46 ± 10.55 11.24 ± 8.18 81.43 0.000* 
lean mass 21.60 ± 5.23 19.41 ± 4.50 3.258 0.001* 
Lean % 82.89 ± 10.40 88.37 ± 8.00 -4.288 0.000* 
Water 15.33 ± 4.01 13.72 ± 3.32 3.181 0.002* 
P < 0.05 is significant; BMI = Body mass index; TSFT = Triceps skin fold thickness; SSFT 
= Subscapular skin fold thickness; MUAC = Midupper arm circumference. 
 
In all subjects and in the female subjects, 
negative significant correlation were detected between 
metabolic control, detected by glycosylated Hb, and 
both of all anthropometric and body composition 
parameters except for the lean % (p < 0.05). 
Glycosylated Hb was significantly positively correlated 
with the lean % (p < 0.05) Table 3. Same results were 
obtained when correlating same metabolic control and 
anthropometric and body composition parameters in 
male group with the exception of fat % and lean %, 
where no significant correlation were detected (p > 
0.05). 
Table 4 showed the association between 
metabolic control and growth deficiency and obesity in 
all subjects of T1DM.  Before  adjustment  for age and  
Table 3: Correlation between metabolic control and both 
anthropometric and body composition parameters in all 
subjects and in sex groups with T1DM. 
 Glycosylated Hb (%) 
 All Subjects Male Female 
 r p r p r p 
Weight (kg) -0.430 0.000 * -0.492 0.000 * -0.370 0.000 * 
Height (cm) -0.296 0.000 * -0.384 0.000 * -0.220 0.001 * 
BMI (kg/m
2
) -0.433 0.000 * -0.492 0.000 * -0.383 0.000 * 
TSFT (mm) -0.274 0.000 * -0.270 0.000* -0.278 0.000 * 
SSFT (mm) -0.240 0.000 * -0.198 0.004 * -0.277 0.000 * 
MUAC (cm) -0.420 0.000 * -0.468 0.000 * -0.368 0.000 * 
Fat mass -0.238 0.000 * -0.167 0.014 * -0.310 0.000 * 
Fat % -0.190 0.000 * -0.077 0.260 -0.313 0.000 * 
Lean mass -0.312 0.000 * -0.398 0.000 * -0.219 0.001 * 
Lean % 0.169 0.000 * 0.066 0.340 0.284 0.000 * 
Water -0.323 0.000 * -0.421 0.000 * -0.214 0.002 * 
P < 0.05 is significant; BMI = Body mass index; TSFT = Triceps skin fold thickness; SSFT 
= Subscapular skin fold thickness; MUAC = Midupper arm circumference. 
 
sex, uncontrolled subjects were significantly more at 
risk of being underweight (W/A z-score ≤ -2) and short 
(H/A z-score ≤ -2), with odds ratio of 15.131 and 
16.877 and 95% confidence interval 1.972-116.130 
and 3.973-71.694 respectively. However, controlled 
subjects were significantly more at risk of being obese 
than the uncontrolled with an odds ratio 0.116 and 
95% confidence interval 0.045-0.302. Same results 
were obtained by using logistic regression after 
adjustment for age and sex. 
Table 4: Association between metabolic control and growth 
deficiency and obesity in all subjects with T1DM before and 
after adjustment for age and sex. 
 Metabolic control 
Chi- 
sqaure 
OR 95% CI p 
 
Controlled 
(No) 
Uncontrolled 
(No) 
Weight:   
11.868 15.131 
1.972-
116.130 
0.001* 
W/A z-score > -2 
W/A z-score ≤ -2 
Total  
214 
1 
215 
198 
14 
212 
Height:    
25.769 16.877 
3.973-
71.694 
0.000* 
H/A z-score > -2 
H/A z=score ≤ -2 
Total  
213 
2 
215 
183 
29 
212 
Obesity   
26.546 0.116 
0.045-
0.302 
0.000* 
BMI z-score < 2  
BMI z-score ≥ 2 
Total  
178 
37 
215 
207 
5 
212 
Logistic regression (after 
adjustment for age and sex) 
Metabolic control  
R
2 
B coefficient OR 95% CI p 
Underweight 
0.045 01.25 14.957 
1.941- 
...1088 
0.009* 
W/A z-score ≤ -2 
 
 
Short Stature 
0.069 2.831 16.955 
3.991- 
.01240 
0.000* H/A z=score ≤ -2 
  
Obesity 
0.086 -2.214 0.109 
0.042-
0.2861 
0.000* BMI z-score ≥ 2 
  
P < 0.05 is significant; W/A = Weight for age; H/A = Height for age; BMI = Body mass 
index; OR = Odds ratio; CI = Confidence interval. 
 
 
Discussion 
 
Type 1 diabetes mellitus (T1DM) is one of the 
most common endocrine and metabolic conditions in 
childhood. Its incidence is increasing worldwide [1]. 
Viral infections, hormones and stress are some of the 
possible causes triggering T1DM. A more frequent 
onset of T1DM at younger age has been described 
and a possible role of milk proteins, gluten or 
vaccinations has been speculated [14]. 
In the current study it was found that females 
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represent 49.9% and males 50.1% of the total diabetic 
children, which suggests a very slight predominance 
of male diabetic children. Similar results had been 
reported in some studies as Baruah et al.,  2011 [10], 
who reported a slight male predominance (56%) found 
among diabetic children which is similar to that of a 
large epidemiologic study among Swedish (Blom et 
al., 1992) [15] and Swiss (Schonle et al., 2001 [16]) 
children. One German study [17] did not find 
significant difference among either sex, whereas the 
Hawaiian IDDM registry [16] showed a higher 
incidence among girls. 
The present study confirmed the importance 
of maintaining good metabolic control to prevent any 
impairment of the longitudinal growth of the diabetic 
children.  To assess the growth of the diabetic 
children we had taking some anthropometric 
measurements, calculating the BMI and measuring 
the body composition. On comparing the two groups 
of the diabetic children together it was found that 
diabetic controlled children were taller and heavier 
with higher BMI than those of the diabetic uncontrolled 
children. Similar to our results several studies have 
suggested growth retardation in children with type 1 
diabetes with suboptimal diabetic control whereas 
other studies have demonstrated normal growth in 
children with good metabolic control. Delayed 
development and onset of puberty in children with 
type 1 diabetes have been reported as well [18].  
Previous studies have documented that poor 
metabolic control was associated with growth 
impairment in diabetic children [19, 20]. In contrast to 
our results, Bognetti et al., 1998 [21], reported that 
height SDS of diabetic children decreased gradually in 
the first 3 years after diagnosis despite adequate 
metabolic control as reflected by their glycosylated 
haemoglobin levels. Other publications also claim that 
the longitudinal growth is impaired in children with T1 
DM, independent of metabolic control [22, 23]. Herber 
and Dunsmore, 1988 [24], found no correlation 
between the height loss from the diagnosis and the 
glycated hemoglobin level, during the period studied. 
So in diabetic controlled children we are in 
agreement with 'the accelerated hypothesis' declared 
by Wilkin in 2001 [25]. Indeed, during the last decade, 
there are some studies reporting positive growth 
characteristics in diabetic children [26&27]. The 
findings of accelerated growth are consistent with the 
hypothesis that increase in stature may be due to 
growth promoting metabolic changes prior to the 
onset of clinical diabetes. Hyperinsulinaemia 
stimulating growth in the prediabetic stage may also 
be a factor [28]. In addition, it has been postulated 
that rapid linear growth may increase insulin demand, 
exhaust pancreatic b cell reserve and precipitating 
clinical expression of the diabetes [15].  
In the current study it was also found that only 
in diabetic uncontrolled children there was a marked 
declining in their growth in all parameters. Studies 
evaluating the course of auxological variables 
following the diagnosis of T1DM generally report 
deterioration in height SDS. These early studies were 
conducted on children who were receiving 
conventional insulin treatment. In this study, they were 
able to evaluate the course of height SDS only in the 
first 5 years of follow−up and found that no significant 
change in height SDS occurred in both sexes. 
Bognetti et al., 1998 [21], found that height SDS 
significantly decreased even in the first 3 years of 
disease in children and adolescents diagnosed 
between 1989 and 1992. Similarly, Donaghue et al., 
2003 [27], found loss of height SDS by the 5th year of 
disease in T1DM patients, diagnosed between 1974 
and 1991. However, Demir et al., 2010 [29], found 
similar to the current results that the 5th year height 
SDS of their patients diagnosed between 1991 and 
1995 were similar to height SDS values at the time of 
diagnosis.   
Growth deceleration during the course of the 
disease has been reported in various countries 
around the world, such as Austria, Brazil, Czech 
Republic, Germany, and Sudan [23, 30-32]. 
In agreement with the current results, Bonfig 
et al., 2012 [33], demonstrated no sex-specific 
differences as regard to anthropometric parameters, 
in contrast to 2 previous studies with smaller patient 
numbers [34, 35]. In a series of 46 patients, Du Caju 
et al., 1995 [34], reported a suboptimal pubertal 
growth spurt resulting in a loss of Ht SDS in 22 girls. 
Kanumakala et al., 2002 [35], found suboptimal 
peripubertal growth in boys; in their growth analysis of 
99 children with type 1 diabetes. Against to our 
results, Wong et al., 2000 [36], in his study provides 
further evidence of sex differences in the growth of 
diabetic children. Boys were tall for age at 
presentation and they achieved average final heights. 
Diabetic girls attained below average adult stature and 
they tended to become obese. The exact reasons for 
such sex differences remain to be defined. Careful 
meal planning and exercise programs are necessary 
to prevent obesity especially for diabetic girls.   
Increased weight and BMI in children who 
have developed diabetes have been reported in some 
studies [37-39], but were not found in others [40, 41]. 
Furthermore, little is known about the effect of type 1 
diabetes on body composition, including fat mass 
(FM), lean body mass (LBM), and BMD in children 
and adolescents [42]. Excess body fat is the main 
cause for health hazards induced by obesity 
(metabolic and cardiovascular disorders), and the 
preservation of fat-free mass (FFM) is a target in the 
treatment of obesity. Treatments of diabetes are 
known to increase weight and the clinical significance 
of the composition of weight gain (fat or fat-free) is 
important. Therefore, an assessment of body 
composition changes is desirable as an evaluation of 
the procedures [43]. 
In the current study it was found that BMI was 
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significantly higher in diabetic controlled than 
uncontrolled children. Concerning the skin fold 
thickness (Triceps and sub scapular) and mid upper 
arm circumference, it was found that the controlled 
diabetic children had higher values than those of the 
uncontrolled in the present study. From these results 
we concluded that the controlled diabetic children had 
more central and peripheral fat distribution than the 
uncontrolled. Moreover, uncontrolled T1DM subjects 
were more at risk of being growth impaired than the 
controlled subjects. In a recent study evaluating 
22651 children with T1DM from specialized centers in 
Germany and Austria, a negative significant 
association between growth deficit and the degree of 
metabolic control was detected which is in agreement 
with the current study [33]. Bizzarri et al. in 2013 [44] 
in a study of 104 T1DM children in Italy found that 
height velocity and BMI were inversely related to 
HbA1c. Same result was detected by Nansel et al., in 
2013 [45] in USA, where BMI was found to be 
inversely related to HbA1c. The results of the previous 
two studies are in concordance with the results of the 
present study. 
In conclusion, the findings of the present 
study suggest that children with uncontrolled T1DM 
are more at risk of being underweight and short, while 
controlled T1DM children may be susceptible to 
weight gain as a result of efforts to control blood 
glucose. Thus, healthcare planners and providers may 
be aware of this growth failure and especially of the 
molecular mechanisms characterizing growth 
alteration in children and adolescents with T1D. This 
is of utmost importance since most of the clinical 
features are reversible with better glycemic control 
and appropriate insulin management. 
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